Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections 2022-09-20 17:00
WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA 2022-09-20 10:48
RemeGen Announces Preliminary Results of Phase III Confirmatory Study of Telitacicept for Treatment of Systemic Lupus Erythematosus (SLE) in China 2022-09-19 21:00
Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium 2022-09-19 20:00
Anyong Biotechnology's Locally Sourced 'Santé Silver Perch Essence' Fulfilling Increasing Demand in The APAC Wellness Industry 2022-09-19 16:30
MagicTouch SCB receives IDE approval for In-Stent Restenosis indication 2022-09-19 12:20
Everest Medicines Appoints Rogers Yongqing Luo as Chief Executive Officer to Lead Next Stage of Company Growth 2022-09-19 08:00
CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte® 2022-09-17 00:20
Austar Lifesciences Announces 2022 Interim Results 2022-09-15 16:53
Winmate Stainless Panel PCs and Displays Solution for Food Packaging Automation 2022-09-15 16:21
SIFI TO PRESENT NEW SCIENTIFIC DATA AND LAUNCH A NEW INTRAOCULAR LENS DURING THE 40TH CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS 2022-09-15 15:00
Juniper Biologics Establishes Global Headquarters in Singapore 2022-09-15 09:53
Transcenta Received IND Clearance from FDA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors 2022-09-14 14:18
Nippon Express Obtains GDP Certification of Compliance with WHO Standards at East Japan Pharmaceutical Center 2022-09-14 14:00
Fosun: Foreign Media Reports about "Regulatory Authorities Asking Banks to Examine their Exposure to Fosun" are Completely False 2022-09-14 12:11
Antengene Unveils Its First Australian Office to Continue Expanding Global Presence 2022-09-14 08:30
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence 2022-09-14 00:48
TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism 2022-09-13 22:15
AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101 2022-09-13 22:00
Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics 2022-09-13 20:38
1 62 63 64 65 66 230